We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $289B
1-Year Est. Return 60.46%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
+3.07%
1 Year Est. Return
+60.46%
3 Year Est. Return
+148.24%
5 Year Est. Return
+163.86%
10 Year Est. Return
+570.16%
AUM
$129B
AUM Growth
-$8.45B
Cap. Flow
+$31.1B
Cap. Flow %
24.16%
Top 10 Hldgs %
38.15%
Holding
4,322
New
186
Increased
1,218
Reduced
1,541
Closed
956

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$3.64B
2
EQIX icon
Equinix
EQIX
+$2.21B
3
TSLA icon
Tesla
TSLA
+$2.19B
4
SNDK
SANDISK CORP
SNDK
+$1.51B
5
TRLA
TRULIA INC (DEL)
TRLA
+$1.5B

Sector Composition

Rank Sector Weight
1 Technology 25.86%
2 Healthcare 23.62%
3 Consumer Discretionary 8.66%
4 Financials 5.93%
5 Real Estate 4.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLRN
3176
DELISTED
Acceleron Pharma
XLRN
$240 ﹤0.01%
7
-72
-91% -$3.25K
MDCO
3177
DELISTED
Medicines Co
MDCO
$239 ﹤0.01%
9
-812
-99% -$26.9K
IMI
3178
DELISTED
Intermolecular, Inc.
IMI
$239 ﹤0.01%
88
-152
-63% -$553
MATX icon
3179
Matsons
MATX
$6.41B
$237 ﹤0.01%
10
-1,511
-99% -$37.3K
REFR icon
3180
Research Frontiers
REFR
$16.8M
$237 ﹤0.01%
52
MCHB
3181
Mechanics Bancorp
MCHB
$3.8B
$236 ﹤0.01%
13
-168
-93% -$3.17K
VXRT
3182
DELISTED
Vaxart
VXRT
$236 ﹤0.01%
6
BIND
3183
DELISTED
BIND THERAPEUTICS INC
BIND
$236 ﹤0.01%
+25
New +$326
CSRE
3184
DELISTED
CSR PLC SPON ADR (UK)
CSRE
$232 ﹤0.01%
6
PTX
3185
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$231 ﹤0.01%
5
-18
-78% -$594
IMNN icon
3186
Imunon
IMNN
$6.64M
0
TRAW icon
3187
Traws Pharma
TRAW
$8.12M
0
BAMM
3188
DELISTED
BOOKS-A-MILLION INC
BAMM
$227 ﹤0.01%
97
BFIN
3189
DELISTED
BankFinancial
BFIN
$226 ﹤0.01%
23
-283
-92% -$2.75K
TUMI
3190
DELISTED
TUMI HLDGS INC COM
TUMI
$225 ﹤0.01%
11
-610
-98% -$13.1K
CCBG icon
3191
Capital City Bank Group
CCBG
$896M
$222 ﹤0.01%
16
-146
-90% -$1.91K
EXAC
3192
DELISTED
Exactech Inc
EXAC
$222 ﹤0.01%
10
-117
-92% -$2.71K
PSUN
3193
DELISTED
PACIFIC SUNWEAR OF CAL. INC
PSUN
$222 ﹤0.01%
77
-521
-87% -$1.52K
MDSO
3194
DELISTED
Medidata Solutions, Inc.
MDSO
$218 ﹤0.01%
6
-684
-99% -$41.7K
MDW
3195
DELISTED
MIDWAY GOLD CORP (CANADA)
MDW
$217 ﹤0.01%
239
-1,217
-84% -$1.36K
FLL icon
3196
Full House Resorts
FLL
$83.5M
$216 ﹤0.01%
108
MPT
3197
Medical Properties Trust
MPT
$2.51B
$216 ﹤0.01%
16
-42,214
-100% -$542K
STRR
3198
DELISTED
Star Equity Holdings
STRR
$216 ﹤0.01%
1
CVV icon
3199
CVD Equipment Corp
CVV
$52.1M
$214 ﹤0.01%
16
MCHX icon
3200
Marchex
MCHX
$77.5M
$213 ﹤0.01%
23
-270
-92% -$2.85K

Similar funds

BNP Paribas Financial Markets's Q1 2014 Portfolio in Review

As of Q1 2014, BNP Paribas Financial Markets held 4,322 positions worth $129B, down 6.2% from $137B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

BNP Paribas Financial Markets deployed $31.1B of net new capital in Q1 2014, opening 186 new positions and adding to 1,218 existing holdings. Its largest new stake was JOYY Inc: 14,000,000 shares worth $1.21B.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $277M trimmed.

  • BNP Paribas Financial Markets's largest Q1 2014 buy was JOYY Inc: 14,000,000 shares worth $1.21B.
  • BNP Paribas Financial Markets added most to Gilead Sciences in Q1 2014, an estimated $3.64B increase.
  • BNP Paribas Financial Markets's biggest Q1 2014 reduction was Alphabet (Google) Class C, cutting an estimated $277M.
  • BNP Paribas Financial Markets fully exited Jakks Pacific in Q1 2014, selling an estimated $231M.
  • BNP Paribas Financial Markets's ten largest holdings make up 38% of its $129B portfolio in Q1 2014.
  • BNP Paribas Financial Markets opened 186 new positions and closed 956 in Q1 2014.
  • BNP Paribas Financial Markets's portfolio value fell 6.2% quarter-over-quarter to $129B.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2014, filed 13 May 2014.